Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C.

Abdallah M. AlQaraawi,Faisal M. Sanai,Hussa Al-Husseini,Ali Albenmousa,Abdulmalik Alsheikh,Lubna Rizwan Ahmed,Ahmad Hersi,Molfi M. Al-Otaibi,Mohammed Syed,Safiyya Ali,Waleed Al Hamoudi,Khalid Alswat,Ayman A. Abdo

Prevalence and impact of hepatic steatosis on the response to antiviral therapy in Saudi patients with genotypes 1 and 4 chronic hepatitis C.

2011

Abdallah M. AlQaraawi
Faisal M. Sanai
Hussa Al-Husseini
Ali Albenmousa
Abdulmalik Alsheikh
Lubna Rizwan Ahmed
Ahmad Hersi
Molfi M. Al-Otaibi
Mohammed Syed
Safiyya Ali
Waleed Al Hamoudi
Khalid Alswat
Ayman A. Abdo

Background Hepatic steatosis in hepatitis C virus (HCV)-infected patients has been shown to enhance the progression of liver fibrosis and decrease the response to antiviral therapy.

Keywords:

Steatosis
Hepatitis C virus
Diabetes mellitus
Internal medicine
Inflammation
Endocrinology
Hepatitis C
Fatty liver
Virology
Interferon
Medicine
Pegylated interferon
Hepatology
Fibrosis
Gastroenterology
Viral disease

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations